Shane Olwill, Chief Development Officer at PIERIS PHARMACEUTICALS, INC. (PIRS), sold 38,400 shares at $5.15 ($196K) on 2021-08-30, disclosed to the SEC on 2021-09-01.
Open-market sale of $196k PIRS by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 9,200 | $46K | 23.4% |
| 2 | $5.15 | 29,200 | $150K | 76.6% |
| Total | $5.11 avg | 38,400 | $196K | 100% |